Table 7. Respondents’ perceptions of areas of further collaboration between pharmacists and physicians (n = 447).
| Area of further collaboration | Agreed n (%) | P-Value | Mean (SD) | Median (IQR) | |||
|---|---|---|---|---|---|---|---|
| Phar | Phys | Phar | Phys | Phar | Phys | ||
| Patient counselling | 223 (97.0) | 202 (93.1) | 0.09 | 4.6 (0.6) | 4.4 (0.6) | 5.0 (1.0) | 5.0 (1.0) |
| Helping in the management of side effects of drug therapy | 221 (96.1) | 201 (92.6) | 0.17 | 4.6 (0.6) | 4.4 (0.7) | 5.0 (1.0) | 4.0 (1.0) |
| Making recommendations to modify a patient’s drug therapy | 197 (85.7) | 196 (90.3) | 0.17 | 4.3 (0.8) | 4.3 (0.7) | 5.0 (1.0) | 4.0 (1.0) |
| Assisting in medication dosage adjustment | 201 (87.4) | 210 (96.8) | <0.001 | 4.4 (0.8) | 4.5 (0.6) | 5.0 (1.0) | 4.0 (1.0) |
| Providing drug information to help select a medication | 202 (87.8) | 202 (93.1) | 0.08 | 4.4 (0.7) | 4.4 (0.6 | 5.0 (1.0) | 4.0 (1.0) |
| Providing advice regarding drug interactions | 207 (90.0) | 200 (92.2) | 0.53 | 4.4 (0.7) | 4.4 (0.7) | 5.0 (1.0) | 4.0 (1.0) |
| Helping to improve patient adherence | 203 (88.3) | 214 (98.6) | <0.001 | 4.4 (0.7) | 4.6 (0.5) | 5.0 (1.0) | 5.0 (1.0) |
| Overall perceptions | 4.4 (0.7) | 4.4 (0.6) | 5.0 (1.0) | 4.0 (1.0) | |||
* Responses rated on a Likert scale ranging from 1 = strongly disagree to 5 = strongly agree.
Phar: Pharmacists; Phys: Physicians